Messenger RNA (mRNA) technology could offer a new approach to [...]

bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

AstraZeneca is presenting a broad package of new clinical and [...]

IMU Biosciences has extended its Series A financing to more [...]

Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

Affibody has reported positive Phase 1 data from its licensee [...]

Syngene International has extended its strategic collaboration with Bristol Myers [...]

Artificial Intelligence, Biotech, Clinical Development, Clinical studies, Drug Development, Partnerships [...]

Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]